Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice
Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial.However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management.Thus, there is an urgent need fox 985-24-100 reservoir shock to bridge this gap betwee